D-TEC® CB Relaunched in United States

Zoetis resumes distribution of canine diagnostic test.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Veterinarians will once again be able to confirm canine brucellosis negative status in approximately two minutes rather than send samples to a lab and wait two or three days for results.

Florham Park, NJ (PRWEB) December 17, 2013

Zoetis announced today the relaunch of D-Tec® CB, a rapid slide agglutination test for detection of canine brucellosis in dogs.

With its return, veterinarians will once again be able to confirm canine brucellosis negative status in approximately two minutes rather than send samples to a lab and wait two or three days for results.

Zoetis acquired the test in 2010 as part of its acquisition of Synbiotics Corporation and stopped selling the test while the manufacturing process underwent review and improvements.

“We are pleased to again provide this convenient, critical test to our customers,” said Constantina Poga, Senior Director, U.S. Diagnostics for Zoetis. ”The test is crucial for responsible canine reproduction.”

Brucella canis can cause severe reproductive disorders including infertility and miscarriages in dogs. Veterinary theriogenologists and the American Kennel Club recommend testing both male and female dogs prior to each breeding.

D-Tec CB is used to confirm the absence of antibodies to the B. canis bacterium and is a recommended test prior to each breeding. Additionally, a positive test result can be confirmed with 2-mercaptoethanol (2-ME), which is included with the test. Product shelf-life is 36 months from the date of manufacture.

For more information about D-Tec CB or to purchase, contact your Zoetis sales representative or go to ZoetisUS.com.

About Zoetis
Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2012, the company generated annual revenues of $4.3 billion. With approximately 9,300 employees worldwide at the beginning of 2013, Zoetis has a local presence in approximately 70 countries, including 29 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information on the company, visit http://www.Zoetis.com.

Zoetis is the proud sponsor with the Smithsonian Institution Traveling Exhibitions and the American Veterinary Medical Association of the mobile educational exhibit Animal Connections: Our Journey Together. Families visiting the exhibit will explore the vast bonds between people and animals and learn about the important role veterinarians play in protecting animal and human health. For more information, visit https://www.Zoetis.com/animal-connections-tour/.


Contact

  • Constantina Poga
    Zoetis
    973.433.3106
    Email